TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

17.90$ -3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OMER
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+2,406.3% +208.1% +55.8% -53.9% +274.3% -34.0% +22.6% -100.0%
-96.1% +35.6% -23.7% -52.5% +418.6% -39.1% -14.2% -31.3% +7,229.7% -98.6%
+222.5% +58.6% -53.9% +271.8% -101.5%
+0.9% +4.8% +9.7% +61.6% +22.1% -1.9% +10.4% -5.1% +1.9% +4.1% -32.0%
+52.4% +25.2% +20.7% -5.4% +31.3% +12.5% -24.6% -7.6% -2.0% +0.2% -16.6%
+18.7% +12.9% +13.9% +31.5% +21.9% -10.0% +10.9% -5.1% +0.7% +2.9% -27.5%
+3.0% +118.8% +41.1% +47.3% +39.4% +18.1% -26.5% +15.4% +35.9% -20.0% -96.1%
+49.6% +92.6% +40.9% -208.4% -203.7% -92.2%
-348.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?